[HTML][HTML] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - Journal of …, 2011 - Springer
Abstract Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
[HTML][HTML] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - Journal of …, 2011 - ncbi.nlm.nih.gov
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
Oral administration of the K. sub. ATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - Journal of …, 2011 - go.gale.com
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
[PDF][PDF] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - 2011 - researchgate.net
Abstract Background: Multiple Sclerosis (MS) is an acquired inflammatory demyelinating
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
[PDF][PDF] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - 2011 - academia.edu
Abstract Background: Multiple Sclerosis (MS) is an acquired inflammatory demyelinating
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
N Virgili, JF Espinosa-Parrilla, P Mancera… - Journal of …, 2011 - europepmc.org
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - 2011 - search.ebscohost.com
The article investigates the impact of oral administration of ATP-sensitive potassium channel
opener diazoxide on induced experimental autoimmune encephalomyelitis (EAE) of a …
opener diazoxide on induced experimental autoimmune encephalomyelitis (EAE) of a …
[PDF][PDF] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa-Parrilla, P Mancera… - 2011 - core.ac.uk
Abstract Background: Multiple Sclerosis (MS) is an acquired inflammatory demyelinating
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
disorder of the central nervous system (CNS) and is the leading cause of nontraumatic …
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
N Virgili, JF Espinosa Parrilla, P Mancera… - … 2011, 8: 149, 2011 - diposit.ub.edu
Background Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …
the central nervous system (CNS) and is the leading cause of nontraumatic disability among …